A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP In Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection
Phase of Trial: Phase I
Latest Information Update: 17 May 2017
At a glance
- Drugs VRC-HIVADV014-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 21 Apr 2010 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 04 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jul 2008 New trial record.